Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Biotechnology

Health Care

Pharmaceutical

Priothera

Priothera's headquarters in Dublin, Ireland

Florent Gros

Malika Souquières

Daniel Ghali

Karen Von Graevenitz

Frédéric David

Brice Suire

Philippe Lievre

Lionel Carnot

Dhaval Patel

Marten Steen

Henry Skinner

Christoph Bucher

Simone Seiter

Manus Rogan

The Healthcare and Regulatory Affairs team at Priothera is responsible for overseeing the clinical development and regulatory compliance of sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies. They ensure that clinical trials adhere to regulatory standards, manage medical guidance and clinical operations, and support the overall strategy to bring new therapies to market safely and effectively.

Healthcare and Regulatory Affairs

The Leadership Team at Priothera oversees the strategic direction and operational management of the company. This team is responsible for guiding clinical development, business strategy, financial planning, commercial strategy, and overall governance to advance the development of S1P receptor modulators for haematological malignancies.

Leadership Team

The Founding Team at Priothera is responsible for steering the company's strategic direction, securing funding, and establishing key business and scientific partnerships. They also oversee product development and commercialization efforts, ensuring alignment with the company's mission to develop orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Founding Team

Priothera

Org chart

Board & advisors

Teams

Healthcare and Regulatory Affairs

Leadership Team

Founding Team

Offices

Priothera

Org chart

Board & advisors

Teams

Healthcare and Regulatory Affairs

Leadership Team

Founding Team

Offices

Related companies